447 related articles for article (PubMed ID: 37067729)
1. Landscape of NcRNAs involved in drug resistance of breast cancer.
Kang Y
Clin Transl Oncol; 2023 Jul; 25(7):1869-1892. PubMed ID: 37067729
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA.
Hayes EL; Lewis-Wambi JS
Breast Cancer Res; 2015 Mar; 17():40. PubMed ID: 25849966
[TBL] [Abstract][Full Text] [Related]
3. Roles of noncoding RNAs in drug resistance in multiple myeloma.
Li J; Zou J; Wan X; Sun C; Chu Z; Hu Y
J Cell Physiol; 2020 Nov; 235(11):7681-7695. PubMed ID: 32324301
[TBL] [Abstract][Full Text] [Related]
4. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer.
Abdollahzadeh R; Daraei A; Mansoori Y; Sepahvand M; Amoli MM; Tavakkoly-Bazzaz J
J Cell Physiol; 2019 Jul; 234(7):10080-10100. PubMed ID: 30537129
[TBL] [Abstract][Full Text] [Related]
5. ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies.
Yang S; Wang X; Zhou X; Hou L; Wu J; Zhang W; Li H; Gao C; Sun C
Biomed Pharmacother; 2023 Jun; 162():114698. PubMed ID: 37060661
[TBL] [Abstract][Full Text] [Related]
6. Noncoding RNAs in gastric cancer: implications for drug resistance.
Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
[TBL] [Abstract][Full Text] [Related]
7. Noncoding RNAs in esophageal cancer: A glimpse into implications for therapy resistance.
Yang Z; Ma R; Li J; Zhao L
Pharmacol Res; 2023 Feb; 188():106678. PubMed ID: 36709789
[TBL] [Abstract][Full Text] [Related]
8. LncRNAs Roles in Chemoresistance of Cancer Cells.
Taghvimi S; Abbaszadeh S; Banan FB; Fard ES; Jamali Z; Najafabadi MA; Savardashtaki A; Movahedpour A
Curr Mol Med; 2022; 22(8):691-702. PubMed ID: 34711162
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Breast Cancer Progression by Noncoding RNAs.
Akshaya RL; Rohini M; Selvamurugan N
Curr Cancer Drug Targets; 2020; 20(10):757-767. PubMed ID: 32652909
[TBL] [Abstract][Full Text] [Related]
10. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of breast cancer resistance to anthracyclines or taxanes: an overview of the proposed roles of noncoding RNA.
Li XJ; Zha QB; Ren ZJ; Tang JH; Yao YF
Curr Opin Oncol; 2015 Nov; 27(6):457-65. PubMed ID: 26371779
[TBL] [Abstract][Full Text] [Related]
12. Targeting non-coding RNAs to overcome cancer therapy resistance.
Chen B; Dragomir MP; Yang C; Li Q; Horst D; Calin GA
Signal Transduct Target Ther; 2022 Apr; 7(1):121. PubMed ID: 35418578
[TBL] [Abstract][Full Text] [Related]
13. The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancer.
Kansara S; Singh A; Badal AK; Rani R; Baligar P; Garg M; Pandey AK
Semin Cancer Biol; 2023 Oct; 95():1-12. PubMed ID: 37364663
[TBL] [Abstract][Full Text] [Related]
14. Predicting resistance to endocrine therapy in breast cancer: It's time for epigenetic biomarkers (Review).
Fontes-Sousa M; Amorim M; Salta S; Palma De Sousa S; Henrique R; Jerónimo C
Oncol Rep; 2019 Mar; 41(3):1431-1438. PubMed ID: 30664168
[TBL] [Abstract][Full Text] [Related]
15. A Panel of Serum Noncoding RNAs for the Diagnosis and Monitoring of Response to Therapy in Patients with Breast Cancer.
Huang SK; Luo Q; Peng H; Li J; Zhao M; Wang J; Gu YY; Li Y; Yuan P; Zhao GH; Huang CZ
Med Sci Monit; 2018 Apr; 24():2476-2488. PubMed ID: 29683112
[TBL] [Abstract][Full Text] [Related]
16. Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications.
Xu S; Wang L; Zhao Y; Mo T; Wang B; Lin J; Yang H
J Biomed Sci; 2024 Feb; 31(1):25. PubMed ID: 38408962
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs.
Abedi-Gaballu F; Kamal Kazemi E; Salehzadeh SA; Mansoori B; Eslami F; Emami A; Dehghan G; Baradaran B; Mansoori B; Cho WC
Cells; 2022 Sep; 11(19):. PubMed ID: 36230935
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
Fanale D; Castiglia M; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
[TBL] [Abstract][Full Text] [Related]
19. Noncoding RNAs in drug-resistant pancreatic cancer: A review.
Lin Z; Lu S; Xie X; Yi X; Huang H
Biomed Pharmacother; 2020 Nov; 131():110768. PubMed ID: 33152930
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between non-coding RNAs expression profile, drug resistance and immune response in breast cancer.
Miraghel SA; Ebrahimi N; Khani L; Mansouri A; Jafarzadeh A; Ahmadi A; Aref AR
Pharmacol Res; 2022 Feb; 176():106041. PubMed ID: 34952200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
